These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

167 related articles for article (PubMed ID: 19565436)

  • 1. Report on the 11- to 13+6-week ultrasound evaluation as a screening test for trisomy 21 in singleton pregnancies.
    Borrell A; Robinson JN; Santolaya-Forgas J
    Am J Perinatol; 2009 Nov; 26(10):703-10. PubMed ID: 19565436
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Additional first-trimester ultrasound markers.
    Sonek J; Nicolaides K
    Clin Lab Med; 2010 Sep; 30(3):573-92. PubMed ID: 20638573
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Assessment of the ductus venosus, tricuspid blood flow and the nasal bone in second-trimester screening for trisomy 21.
    Stressig R; Kozlowski P; Froehlich S; Siegmann HJ; Hammer R; Blumenstock G; Kagan KO
    Ultrasound Obstet Gynecol; 2011 Apr; 37(4):444-9. PubMed ID: 20645398
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Investigation of ultrasound markers in screening fetal trisomy 21].
    Shi XM; Fang Q; Chen BJ; Xie HN; Xie YJ; Chen JH; Wu JZ
    Zhonghua Fu Chan Ke Za Zhi; 2013 Feb; 48(2):81-5. PubMed ID: 23544486
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Second-trimester soft markers: relation to first-trimester nuchal translucency in unaffected pregnancies.
    Miguelez J; De Lourdes Brizot M; Liao AW; De Carvalho MH; Zugaib M
    Ultrasound Obstet Gynecol; 2012 Mar; 39(3):274-8. PubMed ID: 21484908
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Frontomaxillary facial angle in screening for trisomy 21 at 11 + 0 to 13 + 6 weeks.
    Borenstein M; Persico N; Kagan KO; Gazzoni A; Nicolaides KH
    Ultrasound Obstet Gynecol; 2008 Jul; 32(1):5-11. PubMed ID: 18512854
    [TBL] [Abstract][Full Text] [Related]  

  • 7. First trimester ultrasound screening for Down syndrome based on maternal age, fetal nuchal translucency and different combinations of the additional markers nasal bone, tricuspid and ductus venosus flow.
    Abele H; Wagner P; Sonek J; Hoopmann M; Brucker S; Artunc-Ulkumen B; Kagan KO
    Prenat Diagn; 2015 Dec; 35(12):1182-6. PubMed ID: 26223508
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Nuchal fold thickness, nasal bone absence or hypoplasia, ductus venosus reversed flow and tricuspid valve regurgitation in screening for trisomies 21, 18 and 13 in the early second trimester.
    Geipel A; Willruth A; Vieten J; Gembruch U; Berg C
    Ultrasound Obstet Gynecol; 2010 May; 35(5):535-9. PubMed ID: 20183867
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Nuchal translucency and nasal bone for trisomy 21 screening: single center experience.
    Monni G; Zoppi MA; Ibba RM; Floris M; Manca F; Axiana C
    Croat Med J; 2005 Oct; 46(5):786-91. PubMed ID: 16158472
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Assessment of the gap between the fetal nasal bones at 11 to 13 + 6 weeks of gestation by three-dimensional ultrasound.
    Peralta CF; Falcon O; Wegrzyn P; Faro C; Nicolaides KH
    Ultrasound Obstet Gynecol; 2005 May; 25(5):464-7. PubMed ID: 15816008
    [TBL] [Abstract][Full Text] [Related]  

  • 11. First-trimester screening for trisomy 21 using nuchal translucency and nasal bone evaluations in a selected and an unselected population.
    Sonek J; Cicero S; Nicolaides K
    Am J Obstet Gynecol; 2007 Jan; 196(1):e19. PubMed ID: 16996461
    [No Abstract]   [Full Text] [Related]  

  • 12. Choroid plexus cyst, intracardiac echogenic focus, hyperechogenic bowel and hydronephrosis in screening for trisomy 21 at 11 + 0 to 13 + 6 weeks.
    Dagklis T; Plasencia W; Maiz N; Duarte L; Nicolaides KH
    Ultrasound Obstet Gynecol; 2008 Feb; 31(2):132-5. PubMed ID: 18085527
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Additional performance of nasal bone in first trimester screening.
    Kozlowski P; Knippel AJ; Froehlich S; Stressig R
    Ultraschall Med; 2006 Aug; 27(4):336-9. PubMed ID: 16596511
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Screening for fetal abnormalities with ultrasound.
    Flood K; Malone FD
    Curr Opin Obstet Gynecol; 2008 Apr; 20(2):139-45. PubMed ID: 18388813
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Maternal serum biochemistry at 11-13(+6) weeks in relation to the presence or absence of the fetal nasal bone on ultrasonography in chromosomally abnormal fetuses: an updated analysis of integrated ultrasound and biochemical screening.
    Cicero S; Spencer K; Avgidou K; Faiola S; Nicolaides KH
    Prenat Diagn; 2005 Nov; 25(11):977-83. PubMed ID: 16245371
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The absence of the vomer in the first and early second trimester of pregnancy - a new marker of trisomy 21 and trisomy 13.
    Mihailovic T; Stimec BV; Terzic M; Dmitrovic A; Micic J
    Ultraschall Med; 2012 Dec; 33(7):E68-E74. PubMed ID: 21294068
    [TBL] [Abstract][Full Text] [Related]  

  • 17. First-trimester ultrasonographic screening for trisomy 21 using fetal nuchal translucency and nasal bone.
    Sepulveda W; Wong AE; Dezerega V
    Obstet Gynecol; 2007 May; 109(5):1040-5. PubMed ID: 17470580
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Nasal bone assessment in prenatal screening for trisomy 21.
    Sonek JD; Cicero S; Neiger R; Nicolaides KH
    Am J Obstet Gynecol; 2006 Nov; 195(5):1219-30. PubMed ID: 16615922
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Integrated ultrasound and biochemical screening for trisomy 21 using fetal nuchal translucency, absent fetal nasal bone, free beta-hCG and PAPP-A at 11 to 14 weeks.
    Cicero S; Bindra R; Rembouskos G; Spencer K; Nicolaides KH
    Prenat Diagn; 2003 Apr; 23(4):306-10. PubMed ID: 12673635
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Literature review and suggested protocol for managing ultrasound soft markers for Down syndrome: thickened nuchal fold, echogenic bowel, shortened femur, shortened humerus, pyelectasis and absent or hypoplastic nasal bone.
    Bethune M
    Australas Radiol; 2007 Jun; 51(3):218-25. PubMed ID: 17504311
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.